R 613 (Ticlopidine 250 mg)

Pill imprint R 613 has been identified as Ticlopidine hydrochloride 250 mg.

Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ticlopidine hydrochloride

Imprint:

R 613

Strength:

250 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Platelet aggregation inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Actavis

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.